Top

Neurological Sciences

Published in:

01-03-2022 | Status Epilepticus | Original Article

New-onset status epilepticus in SARS-CoV-2 infection: a case series

Authors: Marco Belluzzo, Annacarmen Nilo, Mariarosaria Valente, Gian Luigi Gigli

Published in: Neurological Sciences | Issue 3/2022

Abstract

Background

Neurological manifestations of COVID-19 infection are well recognized. Seizures and status epilepticus (SE) have been reported as possible manifestations and/or complications of SARS-CoV-2 infection at different disease stages, but few data are known about the type, severity, treatment response, and recurrence.

Methods

Single-center retrospective case series.

Results

This case series describes four COVID-19-positive patients admitted to an Italian University Hospital, who developed status epilepticus during the active phase of disease, independently from the severity of respiratory symptoms. Two of them presented a relapse after resolution of the acute viral infection, a feature that has not been previously reported.

Conclusions

Although a possible association between SE and COVID-19 has been reported, the exact etiopathogenetic mechanism remains still not understood. Our series adds new insights to shed further light on this controversial issue.

Dono F, Nucera B, Lanzone J, Evangelista G, Rinaldi F, Speranza R et al (2021) Status epilepticus and COVID-19: a systematic review. Epilepsy Behav 118:107887. https://doi.org/10.1016/j.yebeh.2021.107887CrossRefPubMedPubMedCentral

Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E et al (2015) Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus – approach to clinical application. Epilepsy Behav 49:158–163. https://doi.org/10.1016/j.yebeh.2015.05.007CrossRefPubMed

Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T et al (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143(10):3104–3120. https://doi.org/10.1093/brain/awaa240CrossRefPubMedPubMedCentral

Vohora D, Jain S, Tripathi M, Potschka H (2020) COVID-19 and seizures: is there a link? Epilepsia 61(9):1840–1853. https://doi.org/10.1111/epi.16656CrossRefPubMed

Karvigh SA, Vahabizad F, Mirhadi MS, Banihashemi G, Montazeri M (2021) COVID-19-related refractory status epilepticus with the presence of SARS-CoV-2 (RNA) in the CSF: a case report. Neurol Sci 15:1–4. https://doi.org/10.1007/s10072-021-05239-6CrossRef

Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, Lewis A (2020) Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia 61(10):e135–e139. https://doi.org/10.1111/epi.16683CrossRefPubMed

Manganotti P, Furlanis G, Ajcevic M, Moras C, Bonzi L, Pesavento V, Buoite Stella A. (2021) Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients. J Neurol 1-5. https://doi.org/10.1007/s00415-021-10468-y

Wang C, Kang K, Gao Y, Ye M, Lan X, Li X et al (2020) Cytokine levels in the body fluids of a patient with COVID-19 and acute respiratory distress syndrome: a case report. Ann Intern Med 173(6):499–501. https://doi.org/10.7326/L20-0354CrossRefPubMed

Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S et al (2020) Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol 88(2):423–427. https://doi.org/10.1002/ana.25783CrossRefPubMed

10.

Gigli GL, Vogrig A, Nilo A, Fabris M, Biasotto A, Curcio F et al (2020) HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci 41(12):3391–3394. https://doi.org/10.1007/s10072-020-04787-7CrossRefPubMedPubMedCentral

11.

Monti G, Giovannini G, Marudi A, Bedin R, Melegari A, Simone AM et al (2020) Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure 81:18–20. https://doi.org/10.1016/j.seizure.2020.07.006CrossRefPubMedPubMedCentral

12.

Panariello A, Bassetti R, Radice A, Rossotti R, Puoti M, Corradin M, Moreno M, Percudani M (2020) Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report. Brain Behav Immun 87:179–181. https://doi.org/10.1016/j.bbi.2020.05.054CrossRefPubMedPubMedCentral

13.

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F et al (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18(11):1045–1057. https://doi.org/10.1016/S1474-4422(19)30244-3CrossRefPubMed

14.

Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, Dalmau J (2004) Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 62(5):778–782. https://doi.org/10.1212/01.wnl.0000113749.77217.01CrossRefPubMed

Title: New-onset status epilepticus in SARS-CoV-2 infection: a case series
Authors: Marco Belluzzo
Annacarmen Nilo
Mariarosaria Valente
Gian Luigi Gigli
Publication date: 01-03-2022
Publisher: Springer International Publishing
Keywords: Status Epilepticus
SARS-CoV-2
COVID-19
Published in: Neurological Sciences / Issue 3/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05536-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

New-onset status epilepticus in SARS-CoV-2 infection: a case series

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2022

Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report

Tongue and cerebellar atrophy

Ulnar neuropathy from accessory epitrochlearis anconeus muscle

Time of symptoms beyond the bulbar region predicts survival in bulbar onset amyotrophic lateral sclerosis

Hemodynamic factor evaluation using computational fluid dynamics analysis for de novo bleb formation in unruptured intracranial aneurysms

The clinical and paraclinical correlates of employment status in multiple sclerosis